News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
803,550 Results
Type
Article (65257)
Company Profile (365)
Press Release (737910)
Multimedia
Podcasts (175)
Webinars (27)
Section
Business (220798)
Career Advice (2936)
Deals (38420)
Drug Delivery (151)
Drug Development (88866)
Employer Resources (190)
FDA (18124)
Job Trends (16351)
News (378751)
Policy (38400)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2926)
Academic (1)
Accelerated approval (34)
Adcomms (36)
Allergies (152)
Alliances (54641)
ALS (183)
Alzheimer's disease (1798)
Antibody-drug conjugate (ADC) (352)
Approvals (18308)
Artificial intelligence (595)
Autoimmune disease (172)
Automation (40)
Bankruptcy (395)
Best Places to Work (12222)
BIOSECURE Act (23)
Biosimilars (204)
Biotechnology (235)
Bladder cancer (164)
Brain cancer (66)
Breast cancer (666)
Cancer (5068)
Cardiovascular disease (452)
Career advice (2482)
Career pathing (41)
CAR-T (309)
CDC (59)
Celiac Disease (2)
Cell therapy (815)
Cervical cancer (38)
Clinical research (75223)
Collaboration (1840)
Company closure (4)
Compensation (1189)
Complete response letters (74)
COVID-19 (2987)
CRISPR (99)
C-suite (890)
Cystic fibrosis (155)
Data (6362)
Decentralized trials (2)
Denatured (56)
Depression (151)
Diabetes (536)
Diagnostics (7174)
Digital health (49)
Diversity (12)
Diversity, equity & inclusion (47)
Drug discovery (295)
Drug pricing (227)
Drug shortages (36)
Duchenne muscular dystrophy (244)
Earnings (94487)
Editorial (65)
Employer branding (22)
Employer resources (163)
Events (126875)
Executive appointments (1034)
FDA (21344)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (24)
Funding (1553)
Gene editing (214)
Generative AI (51)
Gene therapy (665)
GLP-1 (1137)
Government (5240)
Grass and pollen (8)
Guidances (386)
Healthcare (20178)
HIV (63)
Huntington's disease (50)
IgA nephropathy (86)
Immunology and inflammation (299)
Immuno-oncology (65)
Indications (106)
Infectious disease (3280)
Inflammatory bowel disease (206)
Inflation Reduction Act (17)
Influenza (122)
Intellectual property (255)
Interviews (535)
IPO (17510)
IRA (60)
Job creations (4480)
Job search strategy (2045)
JPM (69)
Kidney cancer (16)
Labor market (89)
Layoffs (650)
Leadership (40)
Legal (9660)
Liver cancer (98)
Longevity (14)
Lung cancer (686)
Lymphoma (385)
Machine learning (45)
Management (64)
Manufacturing (858)
MASH (174)
Medical device (14668)
Medtech (14724)
Mergers & acquisitions (22003)
Metabolic disorders (1419)
Multiple sclerosis (169)
NASH (23)
Neurodegenerative disease (360)
Neuropsychiatric disorders (101)
Neuroscience (3137)
Neurotech (1)
NextGen: Class of 2026 (7160)
Non-profit (4882)
Now hiring (67)
Obesity (695)
Opinion (332)
Ovarian cancer (170)
Pain (217)
Pancreatic cancer (233)
Parkinson's disease (302)
Partnered (34)
Patents (514)
Patient recruitment (499)
Peanut (61)
People (63843)
Pharmaceutical (75)
Pharmacy benefit managers (33)
Phase 1 (23314)
Phase 2 (32740)
Phase 3 (24649)
Pipeline (5339)
Policy (341)
Postmarket research (3291)
Preclinical (10133)
Press Release (70)
Prostate cancer (252)
Psychedelics (57)
Radiopharmaceuticals (301)
Rare diseases (936)
Real estate (6778)
Recruiting (74)
Regulatory (28248)
Reports (58)
Research institute (2675)
Resumes & cover letters (476)
Rett syndrome (28)
RNA editing (20)
RSV (85)
Schizophrenia (160)
Series A (260)
Series B (199)
Service/supplier (16)
Sickle cell disease (104)
Special edition (27)
Spinal muscular atrophy (175)
Sponsored (48)
Startups (4054)
State (2)
Stomach cancer (20)
Supply chain (110)
Tariffs (101)
The Weekly (117)
Vaccines (1150)
Venture capital (99)
Weight loss (477)
Women's health (92)
Worklife (22)
Date
Today (137)
Last 7 days (633)
Last 30 days (2326)
Last 365 days (31921)
2026 (3325)
2025 (32220)
2024 (37192)
2023 (42083)
2022 (53468)
2021 (58100)
2020 (56779)
2019 (49786)
2018 (37757)
2017 (35698)
2016 (36101)
2015 (41876)
2014 (36206)
2013 (31441)
2012 (33619)
2011 (34143)
2010 (32867)
Location
Africa (1027)
Alabama (91)
Alaska (7)
Arizona (332)
Arkansas (14)
Asia (46670)
Australia (7768)
California (11604)
Canada (3313)
China (1186)
Colorado (495)
Connecticut (502)
Delaware (347)
Europe (104913)
Florida (1717)
Georgia (363)
Hawaii (4)
Idaho (65)
Illinois (915)
India (70)
Indiana (536)
Iowa (23)
Japan (439)
Kansas (128)
Kentucky (41)
Louisiana (28)
Maine (83)
Maryland (1447)
Massachusetts (8412)
Michigan (338)
Minnesota (657)
Mississippi (6)
Missouri (139)
Montana (34)
Nebraska (29)
Nevada (124)
New Hampshire (81)
New Jersey (3119)
New Mexico (32)
New York (3063)
North Carolina (1575)
North Dakota (10)
Northern California (5615)
Ohio (352)
Oklahoma (22)
Oregon (47)
Pennsylvania (2314)
Puerto Rico (24)
Rhode Island (47)
South America (1399)
South Carolina (67)
South Dakota (1)
Southern California (4514)
Tennessee (176)
Texas (1803)
United States (41481)
Utah (347)
Vermont (1)
Virginia (277)
Washington D.C. (86)
Washington State (951)
West Virginia (4)
Wisconsin (125)
Wyoming (2)
803,550 Results for "u s drug testing inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
BrYet US, Inc. Expands Patent Portfolio with New U.S. Patent for Targeted Drug Delivery
Near-term applications include combinations with kinase inhibitors (KIs) that achieve enhanced concentration at target sites and synergistic delivery of multiple KIs to the same location
November 13, 2025
·
1 min read
Artificial intelligence
AI Is Changing Pharma’s Bottom Line Now—But Not Through Splashy Drug Discovery
Pfizer, Eli Lilly, Novartis, Bristol Myers Squibb and AstraZeneca are all ramping up the use of AI, but drug discovery is not the primary success story—yet.
February 11, 2026
·
8 min read
·
Annalee Armstrong
Press Releases
Cardiol Therapeutics Receives U.S. Patent Allowance Broadly Protecting its Heart Drugs to Late 2040
Once issued, this new U.S. patent covers the use of CardiolRx™ and CRD-38 for a broad range of cardiac disorders, including atherosclerosis and heart failure, significantly expanding intellectual property protection in the world’s largest pharmaceutical market. This allowance fortifies Cardiol’s global intellectual property portfolio, adding to granted and pending patent applications in Europe, Japan, Canada, Australia, and China.
November 13, 2025
·
6 min read
Press Releases
U.S. Food and Drug Administration Accepts New Drug Application and Grants Priority Review for Takeda’s Oveporexton (TAK-861) as a Potential First-in-Class Therapy for Narcolepsy Type 1
February 10, 2026
·
8 min read
Press Releases
BioXcel Therapeutics Submits Supplemental New Drug Application to U.S. Food and Drug Administration for IGALMI® Label Expansion in the At-Home Setting
January 20, 2026
·
11 min read
Weight loss
Novo’s Next-Gen Obesity Drug Beats Wegovy on Blood Sugar Control in Phase III
While CagriSema bested Novo Nordisk’s Wegovy on blood sugar control in a late-stage trial, the next-gen weight loss drug still has not met the pharma’s 25% weight loss goal.
February 3, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Egyptian Drug Authority Authorizes Biomerica’s Complete Screening Test Portfolio
December 12, 2025
·
7 min read
Press Releases
PharmaResearch Receives U.S. FDA Clearance to Initiate Phase 1 Clinical Trial of Nano Anticancer Drug, PRD-101
February 6, 2026
·
2 min read
Press Releases
Roxadustat Granted Orphan Drug Designation for the Treatment of Myelodysplastic Syndromes by the U.S. Food and Drug Administration
December 15, 2025
·
6 min read
Press Releases
Johnson & Johnson Submits OTTAVA™ Robotic Surgical System to the U.S. Food and Drug Administration
January 8, 2026
·
5 min read
1 of 80,355
Next